Your browser doesn't support javascript.
loading
The mechanism of thrombocytopenia caused by cholesterol-conjugated antisense oligonucleotides.
Harada, Kosuke; Furukawa, Hideki; Kohara, Hiroshi; Nishimura, Koki; Komori, Hisakazu; Okai, Yoshiko; Arai, Yuta; Yamamoto, Yuhei; Yamamoto, Katsuhiko; Imanishi, Akio; Shinozawa, Tadahiro.
Afiliación
  • Harada K; Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Furukawa H; Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Kohara H; Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Nishimura K; Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Komori H; Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Okai Y; Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Arai Y; Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Yamamoto Y; Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Yamamoto K; Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Imanishi A; Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Shinozawa T; Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan. Electronic address: tadahiro.shinozawa@takeda.com.
Toxicol In Vitro ; 89: 105569, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36801361
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Oligonucleótidos Antisentido Límite: Animals Idioma: En Revista: Toxicol In Vitro Asunto de la revista: TOXICOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Oligonucleótidos Antisentido Límite: Animals Idioma: En Revista: Toxicol In Vitro Asunto de la revista: TOXICOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón